Featured News

Schizophrenia Bulletin follows the movement change to the name and concept of "Schizophrenia", revealing that Japan has taken the lead.  Japan, to remove the...

Although extensive research links spanking to behavior problems, parents who spank often believe it is the way to be an effective parent.  Research from...

An equal percentage of young people will start misusing ADHD-related and other stimulant drugs for the first time at age 13 as will start at age 20.

The Sunday Times of London reports on Peter Gotzsche's efforts to obtain pharmaceutical licensing data before the Medicines and Healthcare Products Regulatory Agency (MHRA)...

LAW360 reports that a Pennsylvania federal judge has dismissed a lawsuit over a movement disorder attributed to Bristol-Myers' drug Abilify.  The judge held that...

Drug companies must start publicly releasing information about different types of payments to Australia's physicians.

Taking the antipsychotic medication risperidone significantly increases men's chances of developing gynecomastia, or breast enlargement, according to a study by University of British Columbia...

A new study investigates how antidepressant withdrawal effects often get confounded with depression relapse in clinical trials.

A study of over 1.5 million people in Europe and the US links the development of less adaptive personalities with childhood lead exposure.

Not an Onion Study: The first-ever injectable antipsychotic that lasts for three months was approved based on one clinical trial in which it prevented relapses better than putting people into sudden withdrawal.

Recently, major researchers, including David Healy, Jon Juriedini, Mickey Nardo, and their colleagues, have brought a great deal of attention to issues of corruption...

A recent review, published in Neuroscience & Biobehavioral Reviews, challenges the dominant assumptions about the neurochemical and therapeutic effects of Selective Serotonin Reuptake Inhibitors...

An entire special issue of the journal Children & Society is dedicated to examining questions surrounding “psychiatrised children.” Various studies explore how rarely children’s...

Researchers argue for a shift away from a focus on antipsychotic adherence toward understanding service users’ diverse patterns of use.

A new study systematically explores critical reactions to the DSM-5 and identifies unifying themes.

A new scale has been developed and validated to examine beliefs held by mental health professionals towards service users’ rights.

Research from Iran points out that "there is no empirical literature about the American Psychiatry Association proposed new diagnostic criteria for attention deficit disorder."...

Taking antidepressant or benzodiazepine medications increases the risks that a person will commit a homicide, according to a study from Finland published in a World Psychiatry letter.

A new article documents the “flimsy evidence” behind the recent FDA approval of the party drug esketamine for the treatment of depression.

A study released this week in JAMA examined whether giving patients with chronic heart failure and depression the SSRI antidepressant escitalopram (Lexapro) for two...

“When people with early-stage symptoms took omega-3 supplements for three months, they had much lower rates of progression than those who did not,” according to research out of Australia covered in this month’s issue of the New Scientist.

The use of antidepressants has increased substantially in recent years, yet relatively few studies have asked patients about their experiences with these drugs. A...

-SSRI antidepressant medications contribute to a significant worsening of emotional "rapid cycling" in patients diagnosed with bipolar disorder.

In a scathing editorial in this month’s Psychotherapy and Psychosomatics, Dr. Giovanni Fava takes aim at prominent medical experts who have downplayed the role...

New strategies for tapering psychiatric drugs achieved by acknowledging withdrawal symptoms and valuing service-users’ first-hand knowledge.